-(BUSINESS WIRE)-- NYSE Euronext (NYX) announced today that it would not pursue an appeal of the decision by the European Commission to prohibit its proposed combination with Deutsche Boerse.
While we continue to believe that the European Commission decision was based on an incorrect determination of the relevant market definition, we do not believe that the interests of our shareholders and our company would be served by undertaking a protracted appeal.
We remain convinced of the original rationale for the proposed combination and the many benefits it would have created for the industry, our customers and the European economy. However, as we said at the time of the prohibition, our sole focus has returned to executing our strategy and leveraging the significant opportunities we have to grow the business and continue to create long-term value for our shareholders, customers and employees.
About NYSE Euronext
NYSE Euronext (NYX) is a leading global operator of financial markets and provider of innovative trading technologies. The company's exchanges in Europe and the United States trade equities, futures, options, fixed-income and exchange-traded products. With approximately 8,000 listed issues (excluding European Structured Products), NYSE Euronext's equities markets – the New York Stock Exchange, NYSE Euronext, NYSE Amex, NYSE Alternext and NYSE Arca – represent one-third of the world's equities trading, the most liquidity of any global exchange group. NYSE Euronext also operates NYSE Liffe, one of the leading European derivatives businesses and the world's second-largest derivatives business by value of trading. The company offers comprehensive commercial technology, connectivity and market data products and services through NYSE Technologies. NYSE Euronext is in the S&P 500 index, and is the only exchange operator in the Fortune 500. For more information, please visit: http://www.nyx.com.
Contacts
NYSE Euronext
Media
Robert Rendine, +1-212-656-2180
or
Caroline Nico, +33-1-4927-1074
or
Investor Relations
Stephen Davidson, +1-212-656-2183
No comments:
Post a Comment